Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer.

Bracken AP, Pasini D, Capra M, Prosperini E, Colli E, Helin K.

EMBO J. 2003 Oct 15;22(20):5323-35.

2.

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells.

Kleer CG, Cao Q, Varambally S, Shen R, Ota I, Tomlins SA, Ghosh D, Sewalt RG, Otte AP, Hayes DF, Sabel MS, Livant D, Weiss SJ, Rubin MA, Chinnaiyan AM.

Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11606-11. Epub 2003 Sep 19.

3.

Gene expression patterns in ovarian carcinomas.

Schaner ME, Ross DT, Ciaravino G, Sorlie T, Troyanskaya O, Diehn M, Wang YC, Duran GE, Sikic TL, Caldeira S, Skomedal H, Tu IP, Hernandez-Boussard T, Johnson SW, O'Dwyer PJ, Fero MJ, Kristensen GB, Borresen-Dale AL, Hastie T, Tibshirani R, van de Rijn M, Teng NN, Longacre TA, Botstein D, Brown PO, Sikic BI.

Mol Biol Cell. 2003 Nov;14(11):4376-86. Epub 2003 Sep 5.

4.

Comparative analyses of multi-species sequences from targeted genomic regions.

Thomas JW, Touchman JW, Blakesley RW, Bouffard GG, Beckstrom-Sternberg SM, Margulies EH, Blanchette M, Siepel AC, Thomas PJ, McDowell JC, Maskeri B, Hansen NF, Schwartz MS, Weber RJ, Kent WJ, Karolchik D, Bruen TC, Bevan R, Cutler DJ, Schwartz S, Elnitski L, Idol JR, Prasad AB, Lee-Lin SQ, Maduro VV, Summers TJ, Portnoy ME, Dietrich NL, Akhter N, Ayele K, Benjamin B, Cariaga K, Brinkley CP, Brooks SY, Granite S, Guan X, Gupta J, Haghighi P, Ho SL, Huang MC, Karlins E, Laric PL, Legaspi R, Lim MJ, Maduro QL, Masiello CA, Mastrian SD, McCloskey JC, Pearson R, Stantripop S, Tiongson EE, Tran JT, Tsurgeon C, Vogt JL, Walker MA, Wetherby KD, Wiggins LS, Young AC, Zhang LH, Osoegawa K, Zhu B, Zhao B, Shu CL, De Jong PJ, Lawrence CE, Smit AF, Chakravarti A, Haussler D, Green P, Miller W, Green ED.

Nature. 2003 Aug 14;424(6950):788-93.

PMID:
12917688
5.

Statistical significance for genomewide studies.

Storey JD, Tibshirani R.

Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9440-5. Epub 2003 Jul 25.

6.

Overexpression of the EGFR/FKBP12/HIF-2alpha pathway identified in childhood astrocytomas by angiogenesis gene profiling.

Khatua S, Peterson KM, Brown KM, Lawlor C, Santi MR, LaFleur B, Dressman D, Stephan DA, MacDonald TJ.

Cancer Res. 2003 Apr 15;63(8):1865-70.

7.

Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays.

Iacobuzio-Donahue CA, Maitra A, Olsen M, Lowe AW, van Heek NT, Rosty C, Walter K, Sato N, Parker A, Ashfaq R, Jaffee E, Ryu B, Jones J, Eshleman JR, Yeo CJ, Cameron JL, Kern SE, Hruban RH, Brown PO, Goggins M.

Am J Pathol. 2003 Apr;162(4):1151-62.

8.

Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning.

Ye QH, Qin LX, Forgues M, He P, Kim JW, Peng AC, Simon R, Li Y, Robles AI, Chen Y, Ma ZC, Wu ZQ, Ye SL, Liu YK, Tang ZY, Wang XW.

Nat Med. 2003 Apr;9(4):416-23. Epub 2003 Mar 17.

PMID:
12640447
9.
10.

Gene expression in lung adenocarcinomas of smokers and nonsmokers.

Powell CA, Spira A, Derti A, DeLisi C, Liu G, Borczuk A, Busch S, Sahasrabudhe S, Chen Y, Sugarbaker D, Bueno R, Richards WG, Brody JS.

Am J Respir Cell Mol Biol. 2003 Aug;29(2):157-62. Epub 2003 Feb 21.

PMID:
12600827
11.

Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray.

Higgins JP, Shinghal R, Gill H, Reese JH, Terris M, Cohen RJ, Fero M, Pollack JR, van de Rijn M, Brooks JD.

Am J Pathol. 2003 Mar;162(3):925-32.

12.

Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis.

Giordano TJ, Thomas DG, Kuick R, Lizyness M, Misek DE, Smith AL, Sanders D, Aljundi RT, Gauger PG, Thompson NW, Taylor JM, Hanash SM.

Am J Pathol. 2003 Feb;162(2):521-31.

13.

Identifying distinct classes of bladder carcinoma using microarrays.

Dyrskjøt L, Thykjaer T, Kruhøffer M, Jensen JL, Marcussen N, Hamilton-Dutoit S, Wolf H, Orntoft TF.

Nat Genet. 2003 Jan;33(1):90-6. Epub 2002 Dec 9.

PMID:
12469123
14.

A molecular signature of metastasis in primary solid tumors.

Ramaswamy S, Ross KN, Lander ES, Golub TR.

Nat Genet. 2003 Jan;33(1):49-54. Epub 2002 Dec 9.

PMID:
12469122
15.

Proteasome inhibitors as new anticancer drugs.

Adams J.

Curr Opin Oncol. 2002 Nov;14(6):628-34. Review.

PMID:
12409653
16.

The polycomb group protein EZH2 is involved in progression of prostate cancer.

Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, Otte AP, Rubin MA, Chinnaiyan AM.

Nature. 2002 Oct 10;419(6907):624-9.

17.

Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma.

Frierson HF Jr, El-Naggar AK, Welsh JB, Sapinoso LM, Su AI, Cheng J, Saku T, Moskaluk CA, Hampton GM.

Am J Pathol. 2002 Oct;161(4):1315-23.

18.

Role of histone H3 lysine 27 methylation in Polycomb-group silencing.

Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P, Jones RS, Zhang Y.

Science. 2002 Nov 1;298(5595):1039-43. Epub 2002 Sep 26.

19.

Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.

Schwartz DR, Kardia SL, Shedden KA, Kuick R, Michailidis G, Taylor JM, Misek DE, Wu R, Zhai Y, Darrah DM, Reed H, Ellenson LH, Giordano TJ, Fearon ER, Hanash SM, Cho KR.

Cancer Res. 2002 Aug 15;62(16):4722-9.

20.

Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays.

Watson MA, Gutmann DH, Peterson K, Chicoine MR, Kleinschmidt-DeMasters BK, Brown HG, Perry A.

Am J Pathol. 2002 Aug;161(2):665-72.

Supplemental Content

Support Center